LumiraDx (LMDX) Prices 43M Share Offering at $1.75/sh Jul 21, 2022 08:37AM
LumiraDx (LMDX) Granted WHO Emergency Use Listing for SARS-CoV-2 Ag Test May 20, 2022 05:47AM
LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test May 20, 2022 05:15AM
LumiraDx (LMDX) Announces Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals Nov 1, 2021 04:40PM
LumiraDx (LMDX) Receives Indian Approval for its COVID-19 Antigen Test Oct 20, 2021 07:05AM